DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 55 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $19,137,602 | +0.3% | 82,725 | +7.5% | 1.50% | -8.5% |
| Q3 2023 | $19,087,822 | +0.6% | 76,936 | -2.7% | 1.64% | +5.5% |
| Q2 2023 | $18,968,640 | -4.0% | 79,036 | +0.8% | 1.56% | -9.7% |
| Q1 2023 | $19,767,245 | -4.2% | 78,429 | +0.8% | 1.72% | -8.0% |
| Q4 2022 | $20,643,837 | +9.0% | 77,778 | +6.1% | 1.87% | -28.5% |
| Q3 2022 | $18,935,000 | +36.0% | 73,308 | +33.5% | 2.62% | +45.0% |
| Q2 2022 | $13,920,000 | -14.3% | 54,908 | -0.9% | 1.80% | +4.8% |
| Q1 2022 | $16,252,000 | -10.6% | 55,408 | +0.3% | 1.72% | -5.3% |
| Q4 2021 | $18,184,000 | +8.8% | 55,269 | +0.7% | 1.82% | -1.9% |
| Q3 2021 | $16,709,000 | +11.7% | 54,888 | -1.5% | 1.85% | +13.5% |
| Q2 2021 | $14,955,000 | +14.0% | 55,726 | -4.4% | 1.63% | +4.9% |
| Q1 2021 | $13,118,000 | +1.9% | 58,281 | +0.6% | 1.56% | -3.8% |
| Q4 2020 | $12,874,000 | +1.1% | 57,958 | -2.0% | 1.62% | -7.1% |
| Q3 2020 | $12,736,000 | +17.7% | 59,146 | -3.4% | 1.74% | +9.7% |
| Q2 2020 | $10,825,000 | +25.9% | 61,218 | -1.5% | 1.59% | +5.5% |
| Q1 2020 | $8,599,000 | -12.3% | 62,126 | -2.8% | 1.50% | +9.8% |
| Q4 2019 | $9,810,000 | +6.8% | 63,916 | +0.5% | 1.37% | -0.9% |
| Q3 2019 | $9,186,000 | -3.9% | 63,606 | -4.9% | 1.38% | -1.8% |
| Q2 2019 | $9,558,000 | +6.2% | 66,878 | -1.9% | 1.41% | +5.1% |
| Q1 2019 | $8,998,000 | +23.9% | 68,163 | -3.2% | 1.34% | +10.0% |
| Q4 2018 | $7,262,000 | -0.4% | 70,426 | +5.0% | 1.22% | +19.3% |
| Q3 2018 | $7,291,000 | +54.4% | 67,094 | +40.2% | 1.02% | +39.1% |
| Q2 2018 | $4,723,000 | +34.8% | 47,862 | +33.7% | 0.73% | +29.5% |
| Q1 2018 | $3,504,000 | +3.6% | 35,787 | -1.8% | 0.57% | +7.6% |
| Q4 2017 | $3,383,000 | +7.1% | 36,452 | -1.0% | 0.53% | +3.7% |
| Q3 2017 | $3,160,000 | +1.4% | 36,834 | -0.3% | 0.51% | +1.4% |
| Q2 2017 | $3,117,000 | -1.3% | 36,934 | 0.0% | 0.50% | -3.8% |
| Q1 2017 | $3,159,000 | +5.8% | 36,934 | -3.7% | 0.52% | -3.3% |
| Q4 2016 | $2,985,000 | -7.0% | 38,352 | -6.4% | 0.54% | -7.4% |
| Q3 2016 | $3,210,000 | -34.6% | 40,954 | -15.8% | 0.58% | -42.4% |
| Q2 2016 | $4,912,000 | +6.0% | 48,632 | -0.4% | 1.01% | +21.5% |
| Q1 2016 | $4,633,000 | +11.7% | 48,837 | +9.3% | 0.83% | +23.1% |
| Q4 2015 | $4,149,000 | +3.9% | 44,669 | -4.7% | 0.68% | +0.3% |
| Q3 2015 | $3,995,000 | +0.6% | 46,884 | +1.1% | 0.67% | +14.4% |
| Q2 2015 | $3,970,000 | -0.6% | 46,384 | -1.4% | 0.59% | 0.0% |
| Q1 2015 | $3,995,000 | -22.4% | 47,059 | -21.6% | 0.59% | -20.8% |
| Q4 2014 | $5,146,000 | +0.4% | 60,034 | -11.0% | 0.74% | +2.3% |
| Q3 2014 | $5,128,000 | -4.4% | 67,491 | -1.0% | 0.73% | -8.7% |
| Q2 2014 | $5,365,000 | +4.0% | 68,141 | -0.9% | 0.80% | -3.9% |
| Q1 2014 | $5,159,000 | -6.1% | 68,781 | -3.3% | 0.83% | -6.1% |
| Q4 2013 | $5,493,000 | +2.7% | 71,154 | -7.8% | 0.88% | -9.7% |
| Q3 2013 | $5,348,000 | +10.5% | 77,151 | +0.9% | 0.98% | +2.1% |
| Q2 2013 | $4,838,000 | – | 76,426 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |